Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulation and immunopharmacology in heart failure
George Markousis‐Mavrogenis, Lukas Baumhove, Ali A. Al‐Mubarak, et al.
Nature Reviews Cardiology (2023) Vol. 21, Iss. 2, pp. 119-149
Closed Access | Times Cited: 22

Showing 22 citing articles:

Association between haemoglobin, albumin, lymphocytes, and platelets and mortality in patients with heart failure
Ling Liu, Benbingdi Gong, Wei Wang, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 2, pp. 1051-1060
Open Access | Times Cited: 15
Burst steroid therapy for acute heart failure: The CORTAHF randomized, open‐label, pilot trial
Gad Cotter, Beth A. Davison, Yonathan Freund, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2282-2292
Open Access | Times Cited: 10
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
Zhuyubing Fang, Umar Raza, Jia Song, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 9
Acute heart failure – transitioning from symptom-based care to remission
Gad Cotter, Beth A. Davison, Douglas L. Mann, et al.
Journal of Cardiac Failure (2025)
Open Access | Times Cited: 1
Inflammation in acute heart failure
Manuel Garofalo, Rossana Corso, Daniela Tomasoni, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 20
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout, et al.
Matrix Biology (2024) Vol. 134, pp. 1-22
Closed Access | Times Cited: 7
IL‐17 is associated with disease severity and targetable inflammatory processes in heart failure
Lukas Baumhove, Bart J van Essen, Martin M. Dokter, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 3530-3538
Open Access | Times Cited: 5
‘Training’ of innate immunity following myocardial infarction exacerbates atherosclerosis
Niranjana Natarajan, Partha Dutta
European Heart Journal (2024) Vol. 45, Iss. 9, pp. 685-687
Open Access | Times Cited: 4
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases
Maya H Buch, Ziad Mallat, Marc R. Dweck, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 614-634
Closed Access | Times Cited: 4
The effects of burst steroid therapy on short-term decongestion in acute heart failure patients with pro-inflammatory activation: a post-hoc analysis of the CORTAHF randomized, open-label, pilot trial.
Jan Biegus, Gad Cotter, Beth A. Davison, et al.
Journal of Cardiac Failure (2024)
Open Access | Times Cited: 4
Metrnl and Cardiomyopathies: From Molecular Mechanisms to Therapeutic Insights
Miaomiao Xu, Xiaoguang Liu, Liming Lu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis
Beth A. Davison, Antonio Abbate, Gad Cotter, et al.
Heart Failure Reviews (2025)
Closed Access
Untangling the role of RhoA in the heart: protective effect and mechanism
Shigeki Miyamoto
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 3
High selenium diet attenuates pressure overload-induced cardiopulmonary oxidative stress, inflammation, and heart failure
Umesh Bhattarai, Rui Xu, Xiaochen He, et al.
Redox Biology (2024) Vol. 76, pp. 103325-103325
Open Access | Times Cited: 3
Neuroimmune cross-talk in heart failure
Sabrina Montuoro, Francesco Gentile, Alberto Giannoni
Cardiovascular Research (2024)
Closed Access | Times Cited: 3
Immunological aspects of central neurodegeneration
Mireia Niso‐Santano, José M. Fuentes, Lorenzo Galluzzi
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Clinical and Proteomic Risk Profiles of New-Onset Heart Failure in Men and Women
Hailun Qin, Jasper Tromp, Jozine M. ter Maaten, et al.
JACC Heart Failure (2024)
Open Access | Times Cited: 2
Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies
Fabrizia Bonacina, David Della‐Morte
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Epigenetic changes in HSCs contribute to HF and comorbidities
Karina Huynh
Nature Reviews Cardiology (2024) Vol. 21, Iss. 8, pp. 522-522
Closed Access
Association between walking pace and heart failure: A Mendelian randomization analysis
He Zheng, Wenbin Wang, Chaolei Chen, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 12, pp. 2713-2719
Closed Access
The immune regulatory role of exosomal miRNAs and their clinical application potential in heart failure
Dandan Guo, Jianjun Yan, Zhenyu Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Cardio-Rheumatology: From Inflammation to Heart Failure. The Emerging Role of Cardiovascular Magnetic Resonance Imaging
George Markousis-Mavrogenis, Alessia Pepe, Monica Mukherjee, et al.
Current Cardiovascular Imaging Reports (2024) Vol. 18, Iss. 1
Closed Access
Page 1

Scroll to top